In a cohort study evaluating immune responses in young adults following administration of a third (mRNA-based) vaccine dose, higher levels of humoral immunity measured by anti-Spike IgG and NAbs were observed in vaccinated individuals with prior SARS-CoV-2 infection (hybrid immunity), compared to vaccinated individuals without prior infection [56]. This evidence concerns the gene CHMP5 and infection.